Ganirelix Acetate recalls
Ganirelix Acetate products have been recalled 1 time, most recently on 17 Dec 2025. The recalling company is usually Lupin Pharmaceuticals. The most common reason is potency & assay.
Total recalls1since 2025
Last 12 months1reported
Class I00% of total
Ongoing1latest 17 Dec 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why ganirelix acetate is recalled
Companies
Product types
By year
Ongoing ganirelix acetate recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Ganirelix Acetate Injection, 250 mcg recalled by Lupin PharmaceuticalsGanirelix Acetate | Lupin Pharmaceuticals | Potency & Assay | 4 states |
All ganirelix acetate recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Ganirelix Acetate Injection, 250 mcg recalled by Lupin PharmaceuticalsGanirelix Acetate | Lupin Pharmaceuticals | Potency & Assay | 4 states |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.